[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Relapsing Multiple Sclerosis (RMS). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Relapsing Multiple Sclerosis (RMS) The report also ...

January 2020 60 pages

Renal Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Renal Anemia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Renal Anemia - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Renal Anemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Renal Anemia development. The report provides ...

January 2020 60 pages

Resistant Hypertension - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Resistant Hypertension - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Resistant Hypertension development. The report provides ...

January 2020 60 pages

Restless Legs Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Restless Legs Syndrome. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Restless Legs Syndrome - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Restless Legs Syndrome The report also ...

January 2020 60 pages

Retinal Vein Occlusion - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Retinal Vein Occlusion. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Retinopathy Of Prematurity - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Retinopathy Of Prematurity The report also ...

January 2020 60 pages

Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Rhino-Conjunctivitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Rhino-Conjunctivitis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Rhino-Conjunctivitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rhino-Conjunctivitis development. The report provides detailed ...

January 2020 60 pages

Rhinosinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Rhinosinusitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Rhinosinusitis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Rhinosinusitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rhinosinusitis development. The report provides detailed ...

January 2020 60 pages

Rhinovirus Infection - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Rhinovirus Infection - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rhinovirus Infection development. The report provides ...

January 2020 60 pages

Rosacea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Rosacea. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Sarcoidosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Sarcoidosis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Schistosomiasis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Schistosomiasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Schistosomiasis development. The report provides detailed ...

January 2020 60 pages

Sciatic Pain - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Sciatic Pain - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Sciatic Pain development. The report provides ...

January 2020 60 pages

Seasonal Allergic Rhinitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Seasonal Allergic Rhinitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 120 pages

Seasonal Allergic Rhinitis - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Seasonal Allergic Rhinitis The report also ...

January 2020 60 pages

Secondary Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Secondary Hyperparathyroidism. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Secondary Hyperparathyroidism - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Secondary Hyperparathyroidism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Secondary Hyperparathyroidism development. The report provides ...

January 2020 60 pages

Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Secondary Progressive Multiple Sclerosis (SPMS). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Secondary Progressive Multiple Sclerosis (SPMS) The report also ...

January 2020 60 pages

Sedation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Sedation. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Sedation - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Sedation - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Sedation development. The report provides detailed ...

January 2020 60 pages

Seizures - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Seizures. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 150 pages

Seizures - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Seizures - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Seizures development. The report provides detailed ...

January 2020 60 pages

Sensory Neuropathy - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Sensory Neuropathy - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Sensory Neuropathy development. The report provides ...

January 2020 60 pages

Septic Shock - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Septic Shock - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Septic Shock development. The report provides ...

January 2020 60 pages

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection The report also ...

January 2020 60 pages

Severe Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Severe Psoriasis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 120 pages

Severe Psoriasis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Severe Psoriasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Severe Psoriasis development. The report provides ...

January 2020 120 pages

Shigella Infections - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Shigella Infections - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Shigella Infections development. The report provides ...

January 2020 60 pages

Short Bowel Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Short Bowel Syndrome. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Sickle Cell Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Sickle Cell Disease. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Sickle Cell Disease - Pipeline Insight, 2020

 US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Sickle Cell Disease The report also ...

January 2020 60 pages

Sinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Sinusitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Sinusitis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Sinusitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Sinusitis development. The report provides detailed ...

January 2020 60 pages

Skin And Skin Structure Infections (SSSI) Caused By Bacteria - Pipeline Insight, 2020

 US$ 1,250.00

... chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Skin And Skin Structure Infections (SSSI) Caused By Bacteria The report also ...

January 2020 60 pages

Sleep Apnea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Sleep Apnea. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Sleep Apnea - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Sleep Apnea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Sleep Apnea development. The report provides ...

January 2020 60 pages

Smallpox - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Smallpox. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Smallpox - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Smallpox - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Smallpox development. The report provides detailed ...

January 2020 60 pages

Smoking Cessation - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Smoking Cessation - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Smoking Cessation development. The report provides ...

January 2020 60 pages

Soft Tissue Sarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Soft Tissue Sarcoma. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Spasticity - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Spasticity. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Spasticity - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Spasticity - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Spasticity development. The report provides detailed ...

January 2020 120 pages

Spinal Muscular Atrophy (SMA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Spinal Muscular Atrophy (SMA). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Status Epilepticus - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Status Epilepticus - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Status Epilepticus development. The report provides ...

January 2020 60 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1